Asset Details
Do you wish to reserve the book?
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Do you wish to request the book?
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
2015
Overview
Background
Flavones found in plants display various biological activities, including anti-allergic, anti-viral, anti-inflammatory, anti-oxidation, and anti-tumor effects. In this study, we investigated the anti-tumor effects of flavone, apigenin and luteolin on human breast cancer cells.
Methods
The anti-cancer activity of flavone, apigenin and luteolin was investigated using the MTS assay. Apoptosis was analyzed by Hoechst 33342 staining, flow cytometry and western blot. Cell migration was determined using the culture inserts and xCELLigence real-time cell analyzer instrument equipped with a CIM-plate 16. Real-time quantitative PCR and western blot were used to determine the signaling pathway elicited by flavone, apigenin and luteolin.
Results
Flavone, apigenin and luteolin showed potent inhibitory effects on the proliferation of Hs578T, MDA-MB-231 and MCF-7 breast cancer cells in a concentration and time-dependent manner. The ability of flavone, apigenin and luteolin to inhibit the growth of breast cancer cells through apoptosis was confirmed by Hoechst33342 staining and the induction of sub-G1 phase of the cell cycle. Flavone, apigenin and luteolin induced forkhead box O3 (FOXO3a) expression by inhibiting Phosphoinositide 3-kinase (PI3K) and protein kinase B (PKB)/Akt. This subsequently elevated the expression of FOXO3a target genes, including the Cyclin-dependent kinase inhibitors p21
Cip1
(p21) and p27
kip1
(p27), which increased the levels of activated poly(ADP) polymerase (PARP) and cytochrome
c
.
Conclusion
Taken together, these data demonstrated that flavone, apigenin and luteolin induced cell cycle arrest and apoptosis in breast cancer cells through inhibiting PI3K/Akt activation and increasing FOXO3a activation, which suggest that flavone, apigenin and luteolin will be the potential leads for the preventing and treating of breast cancer.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
Subject
/ Antineoplastic Agents, Phytogenic - pharmacology
/ Biomedical and Life Sciences
/ Breast Neoplasms - pathology
/ Cell Proliferation - drug effects
/ Cellular signal transduction
/ Complications and side effects
/ Female
/ Flavones
/ Forkhead Transcription Factors - metabolism
/ Health Promotion and Disease Prevention
/ Humans
/ Oncology
/ Proto-Oncogene Proteins c-akt - metabolism
/ Real-Time Polymerase Chain Reaction
